CStone Pharmaceuticals
Jing Liang has worked in various roles in different companies, starting as a Resident Doctor at General Hospital of Nanjing Military Command. They then moved on to roles in healthcare consulting and marketing strategy before landing in their current role as Corporate Strategy Manager at CStone Pharmaceuticals. Jing Liang holds a Master's degree in Endocrinology from Shanghai Medical College of Fudan University.
This person is not in any teams
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.